choline has been researched along with Disease, Pulmonary in 15 studies
Excerpt | Relevance | Reference |
---|---|---|
" Long term administration of CDP-choline appears to be valuable in the maintenance of the phospholipid equilibrium of pulmonary surfactant and in the improvement of the quality of alveolar gas exchange." | 5.27 | [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis]. ( Biot, N; Brune, J; Douss, T; Pacheco, Y; Perrin-Fayolle, M; Pujol, B; Revol, A; Vergnon, JM, 1985) |
"Ambroxol, a drug capable of elevating the phospholipid content in healthy rabbit lungs, was tested on two models of experimental lung injury, lung changes in sepsis induced by a peritonitis and in bromcarbamide intoxication." | 3.67 | Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders. ( Müller, B; von Wichert, P; Wilke, A, 1987) |
"The mortality associated with acute pancreatitis (AP) is largely attributable to abnormalities that occur in distant organs and supportive care remains the only treatment for patients with these complications." | 1.34 | Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury. ( Berenguer-Pina, JJ; Hernández-Espinosa, D; Mota, R; Parrilla, P; Sánchez-Bueno, F; Yélamos, J, 2007) |
"A completely noninvasive animal model of acute pancreatitis-associated lung injury was used to show that neutrophils, activated by pancreatitis, play a key role in mediating pancreatitis-associated lung injury." | 1.30 | The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. ( Bhatia, M; Frossard, JL; Hofbauer, B; Lee, HS; Saluja, AK; Steer, ML, 1998) |
" Long term administration of CDP-choline appears to be valuable in the maintenance of the phospholipid equilibrium of pulmonary surfactant and in the improvement of the quality of alveolar gas exchange." | 1.27 | [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis]. ( Biot, N; Brune, J; Douss, T; Pacheco, Y; Perrin-Fayolle, M; Pujol, B; Revol, A; Vergnon, JM, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (60.00) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, T | 2 |
Sun, YE | 2 |
Chu, XY | 1 |
Yao, SL | 2 |
Yang, B | 1 |
Tian, JH | 2 |
Zhang, JM | 1 |
Fan, KJ | 1 |
PELECH, JT | 1 |
TREADWELL, TW | 1 |
TYLER, MD | 1 |
PULS, RJ | 1 |
Yu, CH | 1 |
Yin, DY | 1 |
Mota, R | 1 |
Sánchez-Bueno, F | 1 |
Berenguer-Pina, JJ | 1 |
Hernández-Espinosa, D | 1 |
Parrilla, P | 1 |
Yélamos, J | 1 |
Bhatia, M | 1 |
Saluja, AK | 1 |
Hofbauer, B | 1 |
Lee, HS | 1 |
Frossard, JL | 1 |
Steer, ML | 1 |
Monteil, C | 1 |
Le Prieur, E | 1 |
Buisson, S | 1 |
Morin, JP | 1 |
Guerbet, M | 1 |
Jouany, JM | 1 |
Quintero, OA | 1 |
Korfhagen, TR | 1 |
Wright, JR | 1 |
Smith, BT | 1 |
Wilke, A | 1 |
Müller, B | 1 |
von Wichert, P | 1 |
Pacheco, Y | 1 |
Douss, T | 1 |
Pujol, B | 1 |
Revol, A | 1 |
Vergnon, JM | 1 |
Biot, N | 1 |
Brune, J | 1 |
Perrin-Fayolle, M | 1 |
Mariani, B | 1 |
Marchioni, GF | 1 |
Capitolo, S | 1 |
Morgan, TE | 1 |
Linehan, W | 1 |
Griffin, JP | 1 |
1 review available for choline and Disease, Pulmonary
Article | Year |
---|---|
Pulmonary surfactant.
Topics: Air Pollution; Animals; Carbohydrates; Cats; Choline; Drowning; Humans; Hypercapnia; Hypoxia; In Vit | 1971 |
2 trials available for choline and Disease, Pulmonary
Article | Year |
---|---|
[Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
Topics: Bilirubin; Choline; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; F | 1974 |
Oral preparations of isoetharine compared with orciprenaline and choline theophyllinate.
Topics: Administration, Oral; Bronchodilator Agents; Choline; Clinical Trials as Topic; Delayed-Action Prepa | 1971 |
12 other studies available for choline and Disease, Pulmonary
Article | Year |
---|---|
[Positron emission tomography with special tracers in pulmonary abnormalities].
Topics: Choline; Diagnosis, Differential; Dideoxynucleosides; Female; Humans; Iodoacetates; Lung Diseases; M | 2010 |
Management of chronic congestive failure and angina pectoris in geriatric patients with choline theophyllinate.
Topics: Aged; Angina Pectoris; Choline; Disease Management; Heart Failure; Humans; Lung Diseases; Theophylli | 1957 |
CHRONIC BRONCHITIS-REVERSIBLE AND NONFATAL.
Topics: Blood Gas Analysis; Bronchitis; Bronchitis, Chronic; Choline; Expectorants; Hematocrit; Humans; Iodi | 1964 |
CLINICAL STUDY WITH OXTRIPHYLLINE-GLYCERYL GUAIACOLATE TABLETS IN CHRONIC PULMONARY DISEASE: A DOUBLE-BLIND CROSSOVER STUDY.
Topics: Biomedical Research; Bronchodilator Agents; Choline; Cross-Over Studies; Double-Blind Method; Drug T | 1964 |
[Value of carbon-11 choline positron emission tomography in patients with pulmonary abnormalities].
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Female; Humans; Lung; Lung Diseases; | 2006 |
Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Choline; Dietar | 2007 |
The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury.
Topics: Acute Disease; Animals; Choline; Diet; Ethionine; Female; Immunization, Passive; Leukocyte Count; Lu | 1998 |
Acrolein toxicity: comparative in vitro study with lung slices and pneumocytes type II cell line from rats.
Topics: Acrolein; Adenosine Triphosphate; Animals; Carbon Radioisotopes; Cell Line; Choline; Culture Techniq | 1999 |
Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Choline; Homeostasis; Lipopolysaccharides; Liposomes; L | 2002 |
Biochemistry and metabolism of pulmonary surface-active material.
Topics: Choline; Humans; Infant, Newborn; Lung; Lung Diseases; Proteins; Pulmonary Surfactants | 1978 |
Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders.
Topics: Ambroxol; Animals; Bromhexine; Choline; Fatty Acids; Female; Lung; Lung Diseases; Male; Peritonitis; | 1987 |
[Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis].
Topics: Adult; Aged; Choline; Cytidine Diphosphate Choline; Female; Humans; Injections, Intramuscular; Lung | 1985 |